SCHEMBL1656437

SCHEMBL1656437

CCS(=O)(=O)c1ccc(Oc2cc3nc(-c4ccccn4)[nH]c3cc2C(C)C(=O)O)cc1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 17/20 0.70
▸ CBFB Q13951 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15158259 0.92 GCK (0.69) GCKCBFB
SCHEMBL2291865 0.88 GCK (0.67) GCKCBFB
SCHEMBL12730498 0.88 GCK (0.67) GCKCBFB
SCHEMBL5071857 0.85 GCK (0.78) GCK
SCHEMBL1656346 0.84 GCK (0.71) GCKCBFB
SCHEMBL1656395 0.84 GCK (0.79) GCKCBFB
SCHEMBL2292330 0.84 GCK (0.66) GCKCBFB
SCHEMBL2291624 0.84 GCK (0.66) GCKCBFB
SCHEMBL1656697 0.84 GCK (0.64) GCK
SCHEMBL1656688 0.83 GCK (0.81) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932394-B2 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents MSD K.K. (JP) 2011-04-26 — — US disclosed
EP-1810969-A1 ARYLOXY-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-07-25 — — EP disclosed
Send feedback